2011/03/17 09:43 - Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that Chief Executive Officer Professor Silviu Itescu has been named BioSpectrum Asia Pacific Person of the Year 2011. BioSpectrum Asia is the leading Asian life sciences publication.
2011/02/28 17:17 - Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today reported its half year results for the period ended 31 December 2010. At the reporting date, Mesoblast recorded funds of $140.6 million but has since nearly doubled its cash reserves to $279 million after an equity purchase by global biopharmaceutical company Cephalon Inc. (NASDAQ:CEPH) that brings its total Mesoblast holding to 19.99%.
2011/02/24 12:10 - Australian Market Report of February 24, 2011 includes: Viralytics Limited (ASX:VLA) received a patent granting notice from China regarding the use of EVATAK(TM) as ovarian cancer treatment; Peak Resources Limited (ASX:PEK) reported the remaining assay results from the November-December 2010 RC and diamond drilling campaign; Ferrum Crescent Limited (ASX:FCR) has commenced drilling at the Moonlight Iron Ore Project in South Africa; United Uranium Limited (ASX:UUL) announced that No.1 Institute of Geology and Minerals of Shandong Province received investment approval; Gindalbie Metals Limited (ASX:GBG) announced today that the maiden shipment of iron ore from the Karara Iron Ore Project in Western Australia will occur within two months.
2011/02/22 12:33 - Benitec Limited (ASX:BLT) (PINK:BNIKF) announce that following the success of the first stage of its anti-viral program to develop an RNA interference (RNAi)-based therapy against Hepatitis B virus, conducted in collaboration with China-based Biomics Biotechnologies Co. Ltd, the companies have reached agreement to proceed to the next stage which is designed to develop an RNAi therapeutic to the point of pre-clinical studies in vivo.
2011/02/21 12:21 - Australian Market Report of February 21, 2011 includes: Prima BioMed Limited (ASX:PRR) will commence the Phrase III clinical trial for what could be the world's first ovarian cancer immunotherapy vaccine; Redstone Resources Limited (ASX:RDS) announced further high grade copper results at the Tollu copper project in Western Australia; Western Desert Resources Limited (ASX:WDR) reported more high-grade iron ore results at Roper Bar Iron Ore Project in the Northern Territory; Canyon Resources Limited (ASX:CAY) updated on accelerated drilling program in Burkina Faso.
2011/02/18 12:02 - Benitec Limited (ASX:BLT) (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, today announces the formation of the Benitec Chief Investigators' Group, bringing together the Company's scientific founders with its collaborative partners.
2011/02/17 12:31 - Benitec Limited (ASX:BLT) (PINK:BNIKF) announce that the United States Patent and Trademark Office has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key '099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA Interference in human therapeutic applications.
2011/02/14 12:20 - Australian Market Report of February 14, 2011 includes: Black Fire Minerals Limited (ASX:BFE) is to acquire 100% of the advanced Pilot Mountain Tungsten-Copper Project in Nevada, USA; Virax Holdings Limited (ASX:VHL) is to develop a novel skin cancer product; Southern Cross Goldfields Limited (ASX:SXG) discovered near-surface high-grade gold deposits in Western Australia; Prosperity Resources Limited (ASX:PSP) commenced gold drilling in Indonesia.
2011/02/14 09:43 - Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today reported that it had issued an additional 24,702,056 ordinary shares to global biopharmaceutical company Cephalon Inc. (NASDAQ:CEPH), and received an additional cash injection of A$139 million. Mesoblast's total cash reserves are now approximately A$280 million.
2011/02/03 10:20 - Universal Biosensors, Inc. (ASX:UBI) today announced that LifeScan's new product, OneTouch Verio (R) has been made available for sale in France. The OneTouch Verio (R) incorporates technology developed by Universal Biosensors and addresses the rapidly growing Self Monitoring Blood Glucose market.
2011/01/12 09:58 - The strategic alliance between regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), and global biopharmaceutical company, Cephalon Inc. (NASDAQ:CEPH), was highlighted at the 29th annual JP Morgan Healthcare Conference in San Francisco yesterday.
2011/01/11 09:13 - Cephalon, Inc. (NASDAQ:CEPH) and Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced positive interim results from Mesoblast's ongoing multi-center Phase 2 trial of its "off-the-shelf" proprietary adult stem cell product Revascor (TM) for patients with congestive heart failure.
2010/12/23 16:18 - Benitec Limited (ASX:BLT) (PINK:BNIKF) is pleased to advise that it will receive a dividend of US$161,674 from its licensee, the California-based biotechnology company, Tacere Therapeutics, Inc.
2010/12/23 10:38 - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that it had completed its acquisition of United States company Angioblast Systems Inc with the issue of 90.8 million ordinary shares to former Angioblast security holders, increasing the total number of shares on offer to 253.8 million shares. Notably, no former Angioblast security holders elected to take a cash entitlement, resulting in a total saving to Mesoblast of approximately A$47 million.
2010/12/21 11:34 - China Bio-Agriculture Industry Summit 2011 will be convened in Shanghai China on February 24-25, 2011. It is committed to providing a comprehensive picture of policy support, market trends, multi-national cooperation in R&D and technical innovations and investment climate of the industry.
2010/12/16 15:42 - Benitec Limited (ASX:BLT) (PINK:BNIKF) announced today that, following the clarification provided by the re-examination decision for the landmark United States Patent 6,573,099 in RNA interference, it has reviewed the claim scope of the pending US applications with its US attorney and has determined a strategy for the continued prosecution of these applications to maximise their benefits, as presaged in the announcement regarding the R&D Pipeline and Strategy on 3 September 2010.
2010/12/13 11:38 - Benitec Limited (ASX:BLT) (PINK:BNIKF) is pleased to announce that the European Patent Office has issued a Communication of Intent to Grant on application 2005 727 680 "Multiple promoter expression cassettes for simultaneous delivery of RNAi agents".
2010/12/08 09:43 - Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY) and global biopharmaceutical company, Cephalon, Inc. (NASDAQ:CEPH), today announced they have entered into a strategic alliance to develop and commercialize novel adult stem cell therapeutics for degenerative conditions of the central nervous and cardiovascular systems. These conditions include Parkinson's disease, Alzheimer's Disease, Congestive Heart Failure and Acute Myocardial Infarction. The alliance also extends to products for augmenting bone marrow transplantation in cancer patients.
2010/11/29 11:51 - Mesoblast Limited (ASX:MSB) (PINK:MBLTY) is pleased to release Chairman's address 2010 Annual General Meeting.
2010/11/26 11:13 - Benitec Limited (ASX:BLT) (PINK:BNIKF) is pleased to release Chairman address to 2010 Annual General Meeting.
2010/11/19 14:47 - Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that the required period for any antitrust objection under the United States Hart-Scott-Rodino(HSR) anti-trust improvement Act 1976 in respect of its acquisition of Angioblast Systems Inc. has expired.
2010/11/16 10:06 - Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) announced that positive preclinical trial results were today presented at the American Heart Association's annual conference in Chicago showing that the company's proprietary allogeneic stem cells can be injected simply, safely, and effectively into the coronary arteries after a heart attack to prevent heart failure.
2010/11/08 10:18 - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (USOTC:MBLTY), today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.
2010/11/08 10:14 - Benitec Limited (ASX:BLT) (PINK:BNIKF), the , the leading company in expressed gene silencing for human therapeutics, announced today that the United States Patent and Trademark Office (USPTO) has issued an official Notice of Intent to Issue an Ex Parte Re-examination Certificate for US Patent 6,573,099 ("the '099 Graham Patent"), the wide-ranging platform technology patent covering the use of expressed RNAi in human therapeutic applications.
2010/11/05 17:40 - Benitec Limited (ASX:BLT) (PINK:BNIKF), the leading company in expressed gene silencing for human therapeutics, announced today that it has been notified overnight by UK patent attorneys that the United Kingdom Intellectual Property Office (UKIPO) has received an application to revoke Benitec's exclusively licensed patent UK Patent no. 2,353,282. The application to revoke was filed by a UK-based patent attorney firm, which may be acting on behalf of a third party who are not disclosed in the application.
2010/10/29 11:33 - Benitec Limited (ASX:BLT) (PINK:BNIKF) has lodged its Statement of Cash Flows for the quarter ended 30 September 2010, showing operating cash outflows of $615,000 and cash at the end of the quarter of $556,000. During the quarter, the Company received funding from the convertible note facility with La Jolla Cove Investors, Inc of $548,000.
2010/10/21 10:21 - Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that interim results from its Phase 2 clinical trial for minimally invasive posterior lumbar spinal fusion showed that its proprietary "off-the-shelf" product NeoFuse (TM) was both safe and effective.
2010/10/20 10:46 - Stockholders of United States adult stem cell company Angioblast Systems Inc. voted unanimously at a special stockholders' meeting held 19 October in favour of becoming a wholly-owned subsidiary of publicly listed global regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY).
2010/10/14 09:41 - Australian regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers.
2010/10/13 13:00 - Following the Demerger of Dart Energy Limited (ASX:DTE) from Arrow Energy Limited (ASX:AOE) (PINK:ARWEF) and the subsequent establishment of Dart as an independent ASX-listed company, the Board has been seeking to build out the executive and management team of Dart.
2010/10/06 13:30 - Australian Market Report of October 6, 2010 includes: Quantum Resources Limited (ASX:QUR) Gardner Range exploration program is underway; Tissue Therapies Limited (ASX:TIS) was granted the third core VitroGro (R) patent in US; International Finance Corporation commits to further investment in Gryphon Minerals Limited (ASX:GRY); Alkane Resources Limited (ASX:ALK) drill results confirm continuity of gold mineralisation in NSW.
2010/10/01 15:04 - Benitec Limited (ASX:BLT) (PINK:BNIKF) is pleased to announce that it has commenced an R&D program to develop an expressed RNAi product for chronic intractable pain associated with diseases such as cancer and HIV.
2010/09/30 14:03 - Benitec Limited (ASX:BLT) (PINK:BNIKF) are pleased to provide this further update on the United States Patent and Trademark Office's (USPTO) Board of Patent Appeals and Interferences decision ("the Decision") reversing all previous rejections in the US 6,573,099 (the '099 Graham patent) appeal.
2010/09/30 10:19 - Benitec Limited (ASX:BLT) (PINK:BNIKF) are delighted to announce that the United States Patent and Trademark Office's (USPTO) Board of Patent Appeals and Interferences has issued a decision reversing all previous rejections in the US 6,573,099 (the '099 Graham patent) appeal.
2010/09/29 11:02 - Benitec Limited (ASX:BLT) (PINK:BNIKF), a leading Australian based company specialising in RNA interference (RNAi) technology, is pleased to announce that the US patent application for "RNAi Expression Constructs" has been successfully granted by the United States Patent and Trademark Office (USPTO) as US Patent No. 7,803,611.
2010/09/22 18:07 - Shareholders of Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today overwhelmingly approved the acquisition of its United States associate company, Angioblast Systems Inc.
2010/09/22 14:38 - Mesoblast Limited (ASX:MSB) (PINK:MBLTY) is pleased to release its Chairman Brian Jamieson's speech at the Extraordinary General Meeting.
2010/09/20 09:28 - Clinical advances by regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) were featured prominently at the 39th annual meeting of the International Society for Experimental Hematology (ISEH) and the Tissue Engineering and Regenerative Medicine International Society (TERMIS) Asia Pacific meeting, both held over the past several days.
2010/09/03 17:40 - Benitec Limited (ASX:BLT) (PINK:BNIKF), a leading Australian based company specialising in RNA interference (RNAi) technology, is pleased to announce a strategy update and broadening of its R&D pipeline following the recent Board and management changes announced earlier this year.
2010/09/02 11:05 - The Directors of Benitec Limited (ASX:BLT) (PINK:BNIKF) are pleased to provide this update on the progress of the patent family "Control of Gene Expression". The "Control of Gene Expression" patents are part of the foundational Graham RNAi patent family. CSIRO and Benitec have received a Notice of Allowance issued by the United States Patent and Trademark Office (USPTO) on 2 September 2010, allowing US patent application 10/759,841 "Synthetic Genes and Genetic Constructs comprising the same".
Biotech